Hepion PharmaceuticalsHEPA
13F holders, Q2 2024 (June 30)24holders −1
1new positions
2sold out
$1.03avg. 13F price*
At the end of Q2 2024, 24 institutions reported holding Hepion Pharmaceuticals Inc. (HEPA) in their 13F filings, down 1 from Q1 2024. 1 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($526K), Vanguard Group Inc. ($130K) and BlackRock Inc. ($85K).
- Company
- Hepion Pharmaceuticals Inc.
- CUSIP
- 426897302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11K |
| Exits | 2 | $112 |
All 13F filers, Q1 2024 → Q2 2024: 160,325 shares bought and 30,367 shares sold, net +129,958 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Armistice Capital, LLC | 0.01% | Add +32.3% | 516,000 | $526K |
| Vanguard Group Inc. | 0.00% | Reduce -18.9% | 127,649 | $130K |
| BlackRock Inc. | 0.00% | No change | 82,954 | $85K |
| Geode Capital Management, LLC | 0.00% | Add +14.7% | 44,543 | $48K |
| State Street Corp. | 0.00% | No change | 15,676 | $17K |
| Susquehanna International Group, LLP | 0.00% | Add +0.0% | 14,638 | $16K |
| Royal Bank of Canada | 0.00% | Add +72500.0% | 14,520 | $15K |
| XTX Topco Ltd | 0.00% | New | 10,161 | $11K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -2.0% | 7,724 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +205.6% | 5,806 | $6K |
| Morgan Stanley | 0.00% | No change | 1,357 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 175 | $179 |
| Osaic Holdings, Inc. | 0.00% | No change | 113 | $115 |
| Group One Trading LLC | 0.00% | Reduce -75.2% | 84 | $91 |
| AdvisorNet Financial, Inc | 0.00% | Reduce -50.0% | 88 | $90 |
| Macquarie Group Ltd. | 0.00% | No change | 88 | $90 |
| UBS Group AG | 0.00% | Reduce -61.8% | 70 | $71 |
| Bank of America Corp. | 0.00% | Add +4500.0% | 46 | $47 |
| Barclays PLC | 0.00% | No change | 16 | $16 |
| Allworth Financial LP | 0.00% | No change | 1 | $2 |
| Signaturefd, LLC | 0.00% | No change | 1 | $1 |
| Harbor Investment Advisory, LLC | 0.00% | No change | 1 | $1 |
| Global Retirement Partners, LLC | 0.00% | No change | 1 | $1 |
| Benjamin F. Edwards & Company, Inc. | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is HEPA's weight in each manager's 13F, not the share of Hepion Pharmaceuticals Inc. the manager owns.